William Rastetter

Director at Grail, Inc.

William Rastetter

William Rastetter

Director at Grail, Inc.

Overview
Career Highlights

Biogen, Inc.
Fate Therapeutics, Inc.
Apoptos, Inc.

RelSci Relationships

2170

Number of Boards

17

Birthday

1956

Age

63

Number of Awards

1

Contact Data
Trying to get in touch with William Rastetter? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals William Rastetter likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Fate Therapeutics, Inc.

Relationship likelihood: Strong

Professional at Theragence, Inc.

Relationship likelihood: Strong

Co-Founder at ARCH Venture Partners

Relationship likelihood: Strong

Founder at Fate Therapeutics, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Dewpoint Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Quanterix Corp.

Relationship likelihood: Strong

Co-Founder at Zogenix, Inc.

Relationship likelihood: Strong

Treasurer & Director at Planned Parenthood of the Pacific Southwest

Relationship likelihood: Strong

Co-Founder at Neurocrine Biosciences Inc.

Relationship likelihood: Strong

Former President & Chief Executive Officer at Neurocrine Biosciences Inc.

Relationship likelihood: Strong

Paths to William Rastetter
Potential Connections via
Relationship Science
You
William Rastetter
Director at Grail, Inc.
Education
BS in Chemistry

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

PhD in Chemistry

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Career History
Director
2016 - Current

GRAIL, Inc. develops technology to early detection of cancer. It engages in developing paradigm changing clinical assays for early cancer detection, based on unique biological insights from high intensity sequencing analysis of circulating cell free nucleic acids. The company was founded in 2016 and is headquartered in Menlo Park, CA.

Advisor
Current

Illumina Ventures focuses on early-stage companies that are pioneering new applications of genomics and enabling precision medicine. The firm invests in life science tools, clinical diagnostics, therapeutics and other opportunities to improve human health.

Interim Chief Executive Officer
2012 - 2012

Fate Therapeutics, Inc. operates as a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorder. The firm programme cellular therapeutics for the treatment of life threatening diseases, hematologic malignancies, genetic disorders and diseases resulting from the dysregulation of the immune system. Its products include ProHema, ProTmune, Adaptive NK, iPSC-derived NK, Programmed CD34 and T cell therapy. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.

Boards & Committees
Chairman
2009 - 2015

Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL), myelofibrosis, small cell lung cancer and prostate cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies

Chairman
2007 - 2009

Apoptos, Inc. discovers and develops small molecule anticancer drugs. The company focuses in drug therapies that directly induce tumor cell apoptosis. It was founded in 2007 and is headquartered in San Diego, CA

Chairman
1986 - 2003

IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company's products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient's blood or lymphatic system. The company was headquartered in San Diego, CA.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$500 - $4,999
2008

The Museum of Photographic Arts' mission is to inspire, educate, and engage the broadest possible audience through the presentation, interpretation, collection, and preservation of photography, film, and video.

Political Donations
$10K
2005

The Democratic Senatorial Campaign Committee is the only organization solely dedicated to electing a Democratic Senate. From grassroots organizing to candidate recruitment to providing campaign funds for tight races, the DSCC is working hard all year, every year to elect Democrats – and give President Obama the help he needs on Capitol Hill to move our country forward.

$250
2003

Representative from California's 53rd Congressional District

$1,000
2002

Representative from California's 53rd Congressional District

Transactions
Details Hidden

Receptos LLC raised money in a private placement transaction

Investments
Details Hidden

Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in Delaware.

Details Hidden

Apoptos, Inc. discovers and develops small molecule anticancer drugs. The company focuses in drug therapies that directly induce tumor cell apoptosis. It was founded in 2007 and is headquartered in San Diego, CA

Details Hidden

Fate Therapeutics, Inc. operates as a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorder. The firm programme cellular therapeutics for the treatment of life threatening diseases, hematologic malignancies, genetic disorders and diseases resulting from the dysregulation of the immune system. Its products include ProHema, ProTmune, Adaptive NK, iPSC-derived NK, Programmed CD34 and T cell therapy. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
Alfred P. Sloan Research Fellowship
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by William Rastetter. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of William Rastetter's profile does not indicate a business or promotional relationship of any kind between RelSci and William Rastetter.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/william-h-rastetter-3226930
  • https://relationshipscience.com/person/william-h-rastetter-3226930